Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member printed grouped question UIN question first answered answering member label attachment file name title
tabling member	label

Search

967474

	registered interest
	date	04/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescription Drugs: Misuse
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what plans they have to secure funding for existing prescribed medicines withdrawal centres.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL9967
	answer	answer is ministerial correction date of answer 17/09/2018 answer text <p>The Parliamentary under Secretary of State (Steve Brine MP) commissioned Public Health England (PHE) to review the evidence for dependence on, and withdrawal from, prescribed medicines. The review was launched in January 2018 and is due to report in spring 2019 and we await its findings. It is the responsibility of local authorities to commission services, such as the provision of withdrawal centres for addiction to prescribed medicines, to meet assessed local need. The Government currently has no plans to increase the number of these centres.</p><p>The Government has no plans to introduce a separate national helpline to support people affected by prescribed drug dependence. Help and advice on prescribed drug dependence is already available from the 111 helpline or NHS Choices. People who feel that they might be dependent on either prescribed or over the counter medicines should seek help from a health professional in the first instance (such as a general practitioner or pharmacist).</p><p>PHE’s review includes prescribed benzodiazepine drug dependence but will not consider evidence further back than 10 years ago. There are no plans to establish a public inquiry into prescribed benzodiazepine drug dependence.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9968 HL9969 HL9971 question first answered 17/09/2018 14:06:06 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

967475

	registered interest
	date	04/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescription Drugs: Misuse
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what plans they have, if any, to increase the number of prescribed medicines withdrawal centres to cover the whole of England.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL9968
	answer	answer is ministerial correction date of answer 17/09/2018 answer text <p>The Parliamentary under Secretary of State (Steve Brine MP) commissioned Public Health England (PHE) to review the evidence for dependence on, and withdrawal from, prescribed medicines. The review was launched in January 2018 and is due to report in spring 2019 and we await its findings. It is the responsibility of local authorities to commission services, such as the provision of withdrawal centres for addiction to prescribed medicines, to meet assessed local need. The Government currently has no plans to increase the number of these centres.</p><p>The Government has no plans to introduce a separate national helpline to support people affected by prescribed drug dependence. Help and advice on prescribed drug dependence is already available from the 111 helpline or NHS Choices. People who feel that they might be dependent on either prescribed or over the counter medicines should seek help from a health professional in the first instance (such as a general practitioner or pharmacist).</p><p>PHE’s review includes prescribed benzodiazepine drug dependence but will not consider evidence further back than 10 years ago. There are no plans to establish a public inquiry into prescribed benzodiazepine drug dependence.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9967 HL9969 HL9971 question first answered 17/09/2018 14:06:06 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

967476

	registered interest
	date	04/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescription Drugs: Misuse
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government whether they will ensure that in establishing a 24 hour helpline for people affected by prescribed medicines addiction they will also ensure that adequate services are in place to refer patients to.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL9969
	answer	answer is ministerial correction date of answer 17/09/2018 answer text <p>The Parliamentary under Secretary of State (Steve Brine MP) commissioned Public Health England (PHE) to review the evidence for dependence on, and withdrawal from, prescribed medicines. The review was launched in January 2018 and is due to report in spring 2019 and we await its findings. It is the responsibility of local authorities to commission services, such as the provision of withdrawal centres for addiction to prescribed medicines, to meet assessed local need. The Government currently has no plans to increase the number of these centres.</p><p>The Government has no plans to introduce a separate national helpline to support people affected by prescribed drug dependence. Help and advice on prescribed drug dependence is already available from the 111 helpline or NHS Choices. People who feel that they might be dependent on either prescribed or over the counter medicines should seek help from a health professional in the first instance (such as a general practitioner or pharmacist).</p><p>PHE’s review includes prescribed benzodiazepine drug dependence but will not consider evidence further back than 10 years ago. There are no plans to establish a public inquiry into prescribed benzodiazepine drug dependence.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9967 HL9968 HL9971 question first answered 17/09/2018 14:06:06 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

967478

	registered interest
	date	04/09/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Benzodiazepines: Misuse
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government whether they will establish a public inquiry into the harmful effects of prescribed benzodiazepine drug dependence over the last 50 years.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL9971
	answer	answer is ministerial correction date of answer 17/09/2018 answer text <p>The Parliamentary under Secretary of State (Steve Brine MP) commissioned Public Health England (PHE) to review the evidence for dependence on, and withdrawal from, prescribed medicines. The review was launched in January 2018 and is due to report in spring 2019 and we await its findings. It is the responsibility of local authorities to commission services, such as the provision of withdrawal centres for addiction to prescribed medicines, to meet assessed local need. The Government currently has no plans to increase the number of these centres.</p><p>The Government has no plans to introduce a separate national helpline to support people affected by prescribed drug dependence. Help and advice on prescribed drug dependence is already available from the 111 helpline or NHS Choices. People who feel that they might be dependent on either prescribed or over the counter medicines should seek help from a health professional in the first instance (such as a general practitioner or pharmacist).</p><p>PHE’s review includes prescribed benzodiazepine drug dependence but will not consider evidence further back than 10 years ago. There are no plans to establish a public inquiry into prescribed benzodiazepine drug dependence.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9967 HL9968 HL9969 question first answered 17/09/2018 14:06:06 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

947564

	registered interest
	date	24/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	PrescQIPP
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of the accuracy of the information provided by PrescQIPP to Clinical Commissioning Groups to aid their commissioning decisions.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL9847
	answer	answer is ministerial correction date of answer 26/07/2018 answer text <p>We have not made any assessment on the accuracy and advice provided by PrescQIPP. Nor have we made any assessment on whether the advice provided by PrescQIPP to clinical commissioning groups (CCGs) is consistent with national guidelines on the prescription of liothyronine to National Health Service patients. We can confirm that we have not received any assurances from PrescQIPP on whether or not it has taken patient stakeholder views into account as it is the responsibility of CCGs to seek any such assurances.</p><p>PrescQIPP is an independent social enterprise and it is for CCGs to decide whether and how they take that guidance into account when making decisions. However, NHS England expects CCGs to have due regard to the guidance <em>Items which should not routinely be prescribed in primary care: Guidance for CCGs,</em> published in November 2017 by NHS England and NHS Clinical Commissioners when considering the prescribing of liothyronine. A copy of the guidance is attached.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9848 HL9849 question first answered 26/07/2018 12:46:36 answering member 4545 label Biography information for Lord O'Shaughnessy attachment 1 file name items-which-should-not-be-routinely-precscribed-in-pc-ccg-guidance.pdf title Items which should not routinely be prescribed
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

947566

	registered interest
	date	24/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Liothyronine
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of whether the advice provided by PresQIPP to Clinical Commissioning Groups is consistent with national guidelines on the prescription of Liothryonine (T3) to NHS patients.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL9848
	answer	answer is ministerial correction date of answer 26/07/2018 answer text <p>We have not made any assessment on the accuracy and advice provided by PrescQIPP. Nor have we made any assessment on whether the advice provided by PrescQIPP to clinical commissioning groups (CCGs) is consistent with national guidelines on the prescription of liothyronine to National Health Service patients. We can confirm that we have not received any assurances from PrescQIPP on whether or not it has taken patient stakeholder views into account as it is the responsibility of CCGs to seek any such assurances.</p><p>PrescQIPP is an independent social enterprise and it is for CCGs to decide whether and how they take that guidance into account when making decisions. However, NHS England expects CCGs to have due regard to the guidance <em>Items which should not routinely be prescribed in primary care: Guidance for CCGs,</em> published in November 2017 by NHS England and NHS Clinical Commissioners when considering the prescribing of liothyronine. A copy of the guidance is attached.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9847 HL9849 question first answered 26/07/2018 12:46:36 answering member 4545 label Biography information for Lord O'Shaughnessy attachment 1 file name items-which-should-not-be-routinely-precscribed-in-pc-ccg-guidance.pdf title Items which should not routinely be prescribed
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

947567

	registered interest
	date	24/07/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	PrescQIPP
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assurances they have received from PresQIPP that when providing guidance to Clinical Commissioning Groups on commissioning decisions it has taken the views of patient stakeholders into account.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL9849
	answer	answer is ministerial correction date of answer 26/07/2018 answer text <p>We have not made any assessment on the accuracy and advice provided by PrescQIPP. Nor have we made any assessment on whether the advice provided by PrescQIPP to clinical commissioning groups (CCGs) is consistent with national guidelines on the prescription of liothyronine to National Health Service patients. We can confirm that we have not received any assurances from PrescQIPP on whether or not it has taken patient stakeholder views into account as it is the responsibility of CCGs to seek any such assurances.</p><p>PrescQIPP is an independent social enterprise and it is for CCGs to decide whether and how they take that guidance into account when making decisions. However, NHS England expects CCGs to have due regard to the guidance <em>Items which should not routinely be prescribed in primary care: Guidance for CCGs,</em> published in November 2017 by NHS England and NHS Clinical Commissioners when considering the prescribing of liothyronine. A copy of the guidance is attached.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL9847 HL9848 question first answered 26/07/2018 12:46:36 answering member 4545 label Biography information for Lord O'Shaughnessy attachment 1 file name items-which-should-not-be-routinely-precscribed-in-pc-ccg-guidance.pdf title Items which should not routinely be prescribed
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1676494

	registered interest
	date	07/12/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Staff
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government whether they plan to produce a strategy to recruit, retrain and develop a skilled project and change professional workforce, to ensure the successful delivery and sustainable long-term benefits of its healthcare policies and reforms.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL977
	answer	answer is ministerial correction date of answer 14/12/2023 answer text <p>The NHS Long Term Workforce Plan (LTWP) sets out the steps the National Health Service and its partners need to take to deliver an NHS workforce that meets the changing needs of the population over the next 15 years. It will put the workforce on a sustainable footing for the long term. We have committed to refreshing the modelling that underpins the plan every two years or in line with fiscal events to ensure that assessments of staff remain accurate against wider operational, financial, and educational planning needs.</p><p>At a local level, NHS organisations are best placed to determine their own recruitment needs, informed by their workforce, service and financial planning and ensuring there is sufficient skilled workforce around project and change management, digital product developers, data scientists and systems architects.</p> answering member printed Lord Markham grouped question UIN HL978 question first answered 14/12/2023 16:32:51 answering member 4948 label Biography information for Lord Markham
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1676495

	registered interest
	date	07/12/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	NHS: Staff
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what steps they are taking to ensure the recruitment and training of essential non-clinical professionals including (1) digital product developers, (2) data scientists, (3) systems architects, and (4) project and change managers, to support the transformation of health and care services.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL978
	answer	answer is ministerial correction date of answer 14/12/2023 answer text <p>The NHS Long Term Workforce Plan (LTWP) sets out the steps the National Health Service and its partners need to take to deliver an NHS workforce that meets the changing needs of the population over the next 15 years. It will put the workforce on a sustainable footing for the long term. We have committed to refreshing the modelling that underpins the plan every two years or in line with fiscal events to ensure that assessments of staff remain accurate against wider operational, financial, and educational planning needs.</p><p>At a local level, NHS organisations are best placed to determine their own recruitment needs, informed by their workforce, service and financial planning and ensuring there is sufficient skilled workforce around project and change management, digital product developers, data scientists and systems architects.</p> answering member printed Lord Markham grouped question UIN HL977 question first answered 14/12/2023 16:32:51 answering member 4948 label Biography information for Lord Markham
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

518800

	registered interest
	date	18/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Prime Minister: Ministerial Policy Advisers
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what action they are taking to ensure that NICE guidance is followed in the use of faecal microbiota transplants in the treatment of recurrent Clostridium difficile.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL94
	answer	answer is ministerial correction date of answer 26/05/2016 answer text <p>The National Institute for Health and Care Excellence has produced guidance on faecal microbiota transplant for recurrent <em>Clostridium difficile</em> infection under the interventional procedure programme. This programme makes recommendations about the safety of the procedures and how well they work. However the guidance does not constitute a direction to National Health Service trusts to provide the interventions. Decisions about whether to provide a treatment are taken locally.</p> answering member printed Lord Prior of Brampton grouped question UIN HL97 question first answered 26/05/2016 16:29:01 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

76618

	registered interest
	date	09/07/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Neurofibromatosis
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what plans they have to develop a national service framework for neurofibromatosis Type 1 sufferers.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL960
	answer	answer is ministerial correction date of answer 14/07/2014 answer text <p>The number of people with neurofibromatosis type 1 (NF1) in England is estimated to number 11,267. The condition can be mild in some patients, manifesting itself only in patches of skin discolouration and soft benign bumps under the skin (neurofibromas), but for others NF1 causes more serious complications, including a rare form of cancer, curvature of the spine and nerve problems caused by more invasive neurofibromas.</p><p> </p><p>Since 1 April 2013, NHS England has been responsible for securing high quality care for all patients with complex NF1 as part of its specialised commissioning responsibilities. NHS England's NF1 service specification clearly sets out what needs to be in place for providers to offer evidence-based, safe and effective care, ensuring equity of access to a nationally consistent, high quality service. Specialist care is delivered by two designated centres based in Manchester (Central Manchester University Hospitals NHS Foundation Trust) and London (Guys and St. Thomas' NHS Foundation Trust, London) and these provide outreach support into other cities. The service is available to all patients with a suspected or confirmed diagnosis of NF1.</p><p> </p><p>The service specification can be viewed on the NHS England website at the following link:</p><p> </p><p>www.england.nhs.uk/wp-content/uploads/2013/06/b13-comp-neurofib-1.pdf.</p> answering member printed Earl Howe grouped question UIN HL961 HL962 question first answered 14/07/2014 16:18:37 answering member 2000 label Biography information for Earl Howe
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

76619

	registered interest
	date	09/07/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Neurofibromatosis
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government how they will ensure a co-ordinated response at local level for neurofibromatosis Type 1 sufferers.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL961
	answer	answer is ministerial correction date of answer 14/07/2014 answer text <p>The number of people with neurofibromatosis type 1 (NF1) in England is estimated to number 11,267. The condition can be mild in some patients, manifesting itself only in patches of skin discolouration and soft benign bumps under the skin (neurofibromas), but for others NF1 causes more serious complications, including a rare form of cancer, curvature of the spine and nerve problems caused by more invasive neurofibromas.</p><p> </p><p>Since 1 April 2013, NHS England has been responsible for securing high quality care for all patients with complex NF1 as part of its specialised commissioning responsibilities. NHS England's NF1 service specification clearly sets out what needs to be in place for providers to offer evidence-based, safe and effective care, ensuring equity of access to a nationally consistent, high quality service. Specialist care is delivered by two designated centres based in Manchester (Central Manchester University Hospitals NHS Foundation Trust) and London (Guys and St. Thomas' NHS Foundation Trust, London) and these provide outreach support into other cities. The service is available to all patients with a suspected or confirmed diagnosis of NF1.</p><p> </p><p>The service specification can be viewed on the NHS England website at the following link:</p><p> </p><p>www.england.nhs.uk/wp-content/uploads/2013/06/b13-comp-neurofib-1.pdf.</p> answering member printed Earl Howe grouped question UIN HL960 HL962 question first answered 14/07/2014 16:18:38 answering member 2000 label Biography information for Earl Howe
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

76620

	registered interest
	date	09/07/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Neurofibromatosis
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what is the scale of neurofibromatosis Type 1 in the United Kingdom.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL962
	answer	answer is ministerial correction date of answer 14/07/2014 answer text <p>The number of people with neurofibromatosis type 1 (NF1) in England is estimated to number 11,267. The condition can be mild in some patients, manifesting itself only in patches of skin discolouration and soft benign bumps under the skin (neurofibromas), but for others NF1 causes more serious complications, including a rare form of cancer, curvature of the spine and nerve problems caused by more invasive neurofibromas.</p><p> </p><p>Since 1 April 2013, NHS England has been responsible for securing high quality care for all patients with complex NF1 as part of its specialised commissioning responsibilities. NHS England's NF1 service specification clearly sets out what needs to be in place for providers to offer evidence-based, safe and effective care, ensuring equity of access to a nationally consistent, high quality service. Specialist care is delivered by two designated centres based in Manchester (Central Manchester University Hospitals NHS Foundation Trust) and London (Guys and St. Thomas' NHS Foundation Trust, London) and these provide outreach support into other cities. The service is available to all patients with a suspected or confirmed diagnosis of NF1.</p><p> </p><p>The service specification can be viewed on the NHS England website at the following link:</p><p> </p><p>www.england.nhs.uk/wp-content/uploads/2013/06/b13-comp-neurofib-1.pdf.</p> answering member printed Earl Howe grouped question UIN HL960 HL961 question first answered 14/07/2014 16:18:38 answering member 2000 label Biography information for Earl Howe
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

518801

	registered interest
	date	18/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Prime Minister: Ministerial Policy Advisers
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what assessment they have made of the outcome and cost effectiveness of the use of faecal microbiota transplants in the treatment of recurrent Clostridium difficile infections.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL95
	answer	answer is ministerial correction date of answer 26/05/2016 answer text <p>The National Institute for Health and Care Excellence (NICE) has produced guidance on faecal microbiota transplant for recurrent <em>Clostridium difficile</em> infection. NICE has recommended that the procedure is safe enough for use in the National Health Service, but no assessment of its cost effectiveness has been made by NICE.</p><p> </p><p>Data on the uptake by the NHS of faecal microbiota transplants in the treatment of recurrent <em>Clostridium difficile</em> is not collected centrally.</p> answering member printed Lord Prior of Brampton grouped question UIN HL96 question first answered 26/05/2016 16:25:27 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

386454

	registered interest
	date	30/06/2015
	answering body	Department for Culture Media and Sport
	answering dept id	10
	answering dept short name	Culture, Media and Sport
	answering dept sort name	Culture, Media and Sport
	hansard heading	BBC: Midlands
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what discussions they have had with the BBC regarding its levels of investment in the Midlands.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL949
	answer	answer is ministerial correction date of answer 13/07/2015 answer text <p>No such discussions have taken place. However these very issues were discussed by the Minister for Culture in a Westminster Hall debate on 23 June this year. The Secretary of State will be announcing the process for Charter Review in due course, but the level of investment in the Midlands or elsewhere is ultimately a matter for the BBC.</p> answering member printed Baroness Neville-Rolfe grouped question UIN HL950 question first answered 13/07/2015 15:04:26 answering member 4284 label Biography information for Baroness Neville-Rolfe
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

518802

	registered interest
	date	18/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Burial and Cremation
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what assessment they have made of the rate of uptake by the NHS of faecal microbiota transplants in the treatment of recurrent Clostridium difficile infections.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL96
	answer	answer is ministerial correction date of answer 26/05/2016 answer text <p>The National Institute for Health and Care Excellence (NICE) has produced guidance on faecal microbiota transplant for recurrent <em>Clostridium difficile</em> infection. NICE has recommended that the procedure is safe enough for use in the National Health Service, but no assessment of its cost effectiveness has been made by NICE.</p><p> </p><p>Data on the uptake by the NHS of faecal microbiota transplants in the treatment of recurrent <em>Clostridium difficile</em> is not collected centrally.</p> answering member printed Lord Prior of Brampton grouped question UIN HL95 question first answered 26/05/2016 16:25:27 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

731086

	registered interest
	date	21/06/2017
	answering body	Cabinet Office
	answering dept id	53
	answering dept short name	Cabinet Office
	answering dept sort name	Cabinet Office
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government how they have ensured since the 2015 general election that Special Advisers employed in 10 Downing Street do not do anything which is inconsistent with their obligations under the Civil Service Code and Code of Conduct of Special Advisers or behave in a way which is inconsistent with standards set by their employing department.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL94
	answer	answer is ministerial correction date of answer 29/06/2017 answer text <p>The standards of conduct expected of all civil servants, including Special Advisers are set out in the relevant Codes of Conduct. These Codes make clear what Special Advisers can and cannot do in their roles.</p> answering member printed Lord Young of Cookham grouped question UIN HL95 HL97 HL99 question first answered 29/06/2017 16:26:34 answering member 57 label Biography information for Lord Young of Cookham
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

386455

	registered interest
	date	30/06/2015
	answering body	Department for Culture Media and Sport
	answering dept id	10
	answering dept short name	Culture, Media and Sport
	answering dept sort name	Culture, Media and Sport
	hansard heading	BBC: Birmingham
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what discussions they have had with the BBC about the reduction in programme-making at the Mailbox in Birmingham.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL950
	answer	answer is ministerial correction date of answer 13/07/2015 answer text <p>No such discussions have taken place. However these very issues were discussed by the Minister for Culture in a Westminster Hall debate on 23 June this year. The Secretary of State will be announcing the process for Charter Review in due course, but the level of investment in the Midlands or elsewhere is ultimately a matter for the BBC.</p> answering member printed Baroness Neville-Rolfe grouped question UIN HL949 question first answered 13/07/2015 15:04:26 answering member 4284 label Biography information for Baroness Neville-Rolfe
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

518803

	registered interest
	date	18/05/2016
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Prime Minister: Ministerial Policy Advisers
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what action they are taking to ensure that NICE guidance is followed in the use of faecal microbiota transplants in the treatment of recurrent Clostridium difficile infections.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL97
	answer	answer is ministerial correction date of answer 26/05/2016 answer text <p>The National Institute for Health and Care Excellence has produced guidance on faecal microbiota transplant for recurrent <em>Clostridium difficile</em> infection under the interventional procedure programme. This programme makes recommendations about the safety of the procedures and how well they work. However the guidance does not constitute a direction to National Health Service trusts to provide the interventions. Decisions about whether to provide a treatment are taken locally.</p> answering member printed Lord Prior of Brampton grouped question UIN HL94 question first answered 26/05/2016 16:29:01 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

731087

	registered interest
	date	21/06/2017
	answering body	Cabinet Office
	answering dept id	53
	answering dept short name	Cabinet Office
	answering dept sort name	Cabinet Office
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government how they have ensured that Special Advisers employed in 10 Downing Street behave in a way which is professional and which deserves and retains the confidence of all those with whom they have dealings.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL95
	answer	answer is ministerial correction date of answer 29/06/2017 answer text <p>The standards of conduct expected of all civil servants, including Special Advisers are set out in the relevant Codes of Conduct. These Codes make clear what Special Advisers can and cannot do in their roles.</p> answering member printed Lord Young of Cookham grouped question UIN HL94 HL97 HL99 question first answered 29/06/2017 16:26:34 answering member 57 label Biography information for Lord Young of Cookham
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

731089

	registered interest
	date	21/06/2017
	answering body	Cabinet Office
	answering dept id	53
	answering dept short name	Cabinet Office
	answering dept sort name	Cabinet Office
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government whether the Civil Service Code and Code of Conduct for Special Advisers permits Special Advisers to restrict access by senior civil servants to the Prime Minister.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL97
	answer	answer is ministerial correction date of answer 29/06/2017 answer text <p>The standards of conduct expected of all civil servants, including Special Advisers are set out in the relevant Codes of Conduct. These Codes make clear what Special Advisers can and cannot do in their roles.</p> answering member printed Lord Young of Cookham grouped question UIN HL94 HL95 HL99 question first answered 29/06/2017 16:26:34 answering member 57 label Biography information for Lord Young of Cookham
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

731091

	registered interest
	date	21/06/2017
	answering body	Cabinet Office
	answering dept id	53
	answering dept short name	Cabinet Office
	answering dept sort name	Cabinet Office
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government whether they have any evidence that any Special Advisers employed in 10 Downing Street unduly influenced the appointment, removal and replacement of civil servants in breach of the Code of Conduct of Special Advisers.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL99
	answer	answer is ministerial correction date of answer 29/06/2017 answer text <p>The standards of conduct expected of all civil servants, including Special Advisers are set out in the relevant Codes of Conduct. These Codes make clear what Special Advisers can and cannot do in their roles.</p> answering member printed Lord Young of Cookham grouped question UIN HL94 HL95 HL97 question first answered 29/06/2017 16:26:34 answering member 57 label Biography information for Lord Young of Cookham
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1244631

	registered interest
	date	19/10/2020
	answering body	Cabinet Office
	answering dept id	53
	answering dept short name	Cabinet Office
	answering dept sort name	Cabinet Office
	hansard heading	Government Departments: Digital Technology
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government, further to the Written Answer by Lord True on 1 October (HL8184), which members of the Digital Economy Council were invited to contribute to the review of their Digital Data and Technology function over the summer.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL9286
	answer	answer is ministerial correction date of answer 13/11/2020 answer text <p>The review was commissioned and overseen by the Chief Operating Officer for the Civil Service and Cabinet Office Permanent Secretary, Alex Chisholm. Announcements will be made in the usual way.</p> answering member printed Lord True grouped question UIN HL9287 HL9288 question first answered 13/11/2020 14:49:54 answering member 4200 label Biography information for Lord True
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1244632

	registered interest
	date	19/10/2020
	answering body	Cabinet Office
	answering dept id	53
	answering dept short name	Cabinet Office
	answering dept sort name	Cabinet Office
	hansard heading	Government Departments: Digital Technology
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government, further to the Written Answer by Lord True on 1 October (HL8184), what were the terms of reference of the recent review into their Digital Data and Technology function.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL9287
	answer	answer is ministerial correction date of answer 13/11/2020 answer text <p>The review was commissioned and overseen by the Chief Operating Officer for the Civil Service and Cabinet Office Permanent Secretary, Alex Chisholm. Announcements will be made in the usual way.</p> answering member printed Lord True grouped question UIN HL9286 HL9288 question first answered 13/11/2020 14:49:54 answering member 4200 label Biography information for Lord True
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1244634

	registered interest
	date	19/10/2020
	answering body	Cabinet Office
	answering dept id	53
	answering dept short name	Cabinet Office
	answering dept sort name	Cabinet Office
	hansard heading	Government Departments: Digital Technology
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government, further to the Written Answer by Lord True on 1 October (HL8184), which (1) processes, (2) structures, and (3) operations, of the Digital Data and Technology function were considered as part of the review they carried out over the summer.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL9288
	answer	answer is ministerial correction date of answer 13/11/2020 answer text <p>The review was commissioned and overseen by the Chief Operating Officer for the Civil Service and Cabinet Office Permanent Secretary, Alex Chisholm. Announcements will be made in the usual way.</p> answering member printed Lord True grouped question UIN HL9286 HL9287 question first answered 13/11/2020 14:49:55 answering member 4200 label Biography information for Lord True
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

347224

	registered interest
	date	28/05/2015
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Health Services: Staffordshire
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty’s Government what action they are taking to ensure the viability of comprehensive patient services in the Staffordshire local health economy.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL88
	answer	answer is ministerial correction date of answer 09/06/2015 answer text <p>NHS England has identified the Staffordshire clinical commissioning groups (CCGs) as high risk, and as such is monitoring their performance on a monthly basis with a full quarterly review of finance and performance. NHS England increases the intensity of performance reviews where there are significant shortfalls. This includes weekly meetings with CCGs where appropriate.</p><p> </p><p> </p><p> </p><p>Collaborative working relationships are a critical factor in securing sustainable services in any local health economy. The Commissioning Congress has been set up in Staffordshire to bring together both CCGs and local authority commissioners. The Congress will lead the Transformation Strategy which will drive the service redesign of the Staffordshire Health and Social Care economy to secure financial and clinically sustainable services in the long term. The Congress will engage with local providers in developing these plans to ensure that there is a single five-year plan for the local health economy. This work will lead to a full public consultation on those services during the autumn of 2015.</p><p> </p><p> </p><p> </p><p> </p><p> </p><p>The Congress brings together the combined skills, knowledge and expertise of commissioners to work the provider sector on defining the range, scale and scope of services changes to ensure Staffordshire is both clinically and financially sustainable in the long term.</p><p> </p> answering member printed Lord Prior of Brampton grouped question UIN HL90 HL91 HL92 HL93 question first answered 09/06/2015 12:42:46 answering member 127 label Biography information for Lord Prior of Brampton
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1649511

	registered interest
	date	03/07/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescription Drugs: Addictions
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what assessment they have made of long-term and permanent harm caused by the use of benzodiazepines, Z-drugs and antidepressants.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL8988
	answer	answer is ministerial correction date of answer 26/07/2023 answer text <p>The safety of medicines on the United Kingdom market are continuously monitored by the Medicines and Healthcare products Regulatory Agency (MHRA). There are currently no plans to conduct any further reviews into the harms associated with benzodiazepines, Z-drugs and antidepressants, however, any new data would be carefully considered. Details about the possible risks and side effects are outlined in the product information available for each medicine.</p><p>Benzodiazepines and Z-drugs are authorised for short term use, two to four weeks, and should not be used long term due to the risk of dependence and subsequent withdrawal reactions. Healthcare professionals have been reminded of these risks by the MHRA, the Department and professional bodies which have highlighted the extensive warnings about the risks of dependence, the need to limit prescribing and advice about gradual withdrawal.</p> answering member printed Lord Markham grouped question UIN HL8989 question first answered 26/07/2023 13:29:24 answering member 4948 label Biography information for Lord Markham
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1649512

	registered interest
	date	03/07/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Benzodiazepines: Addictions
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government whether they intend to conduct a review of efficacy, safety and risk of addiction relating to the long-term use of benzodiazepines.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL8989
	answer	answer is ministerial correction date of answer 26/07/2023 answer text <p>The safety of medicines on the United Kingdom market are continuously monitored by the Medicines and Healthcare products Regulatory Agency (MHRA). There are currently no plans to conduct any further reviews into the harms associated with benzodiazepines, Z-drugs and antidepressants, however, any new data would be carefully considered. Details about the possible risks and side effects are outlined in the product information available for each medicine.</p><p>Benzodiazepines and Z-drugs are authorised for short term use, two to four weeks, and should not be used long term due to the risk of dependence and subsequent withdrawal reactions. Healthcare professionals have been reminded of these risks by the MHRA, the Department and professional bodies which have highlighted the extensive warnings about the risks of dependence, the need to limit prescribing and advice about gradual withdrawal.</p> answering member printed Lord Markham grouped question UIN HL8988 question first answered 26/07/2023 13:29:24 answering member 4948 label Biography information for Lord Markham
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

931632

	registered interest
	date	26/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Liothyronine
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what action they propose to ensure that the Brighton and Sussex University Hospitals NHS Trust withdraws its policy of no longer making Liothyronine (T3) available to NHS patients, contrary to advice issued by NHS England which sets out the circumstances under which Liothyronine (T3) can be prescribed to new patients and continued for existing patients.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL8980
	answer	answer is ministerial correction date of answer 10/07/2018 answer text <p>The national guidelines advise clinical commissioning groups (CCGs) that local decisions should be made regarding arrangements for the on-going prescribing of liothyronine, taking into account the local needs of the population. While CCGs are expected to have regard to national guidance, they are entitled to develop their own local approaches to its implementation. During a debate on 20 June on the Branded Health Service Medicines (Costs) Regulations, I committed to pursuing further with NHS England ways in which they can clarify the guidelines on the prescribing of liothyronine to CCGs, including looking at whether greater clarity on the criteria for appropriate patient usage is merited.</p><p>The prescribing of Liothyronine (T3) was considered by the Sussex and East Surrey Sustainability and Transformation Partnership (STP) clinical board, which covers Brighton and Sussex University Hospitals, and High Weald, Lewes and Havens CCG, following engagement with primary care clinicians and endocrinologists. Based on the evidence presented, the decision not to routinely prescribe Liothyronine (T3) was supported across the STP region. It was, however, recognised that there would be some exceptions to this and that the use of the individual funding request triage process would be an appropriate mechanism to consider these.</p><p><strong> </strong></p> answering member printed Lord O'Shaughnessy grouped question UIN HL8981 HL8982 HL8983 question first answered 10/07/2018 15:41:18 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

931633

	registered interest
	date	26/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Liothyronine
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what action they propose to take to ensure that the High Weald, Lewes and Havens Clinical Commissioning Group withdraws its policy of no longer making Liothyronine (T3) available to NHS patients, contrary to advice issued by NHS England which sets out the circumstances under which Liothyronine (T3) can be prescribed to new patients and continued for existing patients.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL8981
	answer	answer is ministerial correction date of answer 10/07/2018 answer text <p>The national guidelines advise clinical commissioning groups (CCGs) that local decisions should be made regarding arrangements for the on-going prescribing of liothyronine, taking into account the local needs of the population. While CCGs are expected to have regard to national guidance, they are entitled to develop their own local approaches to its implementation. During a debate on 20 June on the Branded Health Service Medicines (Costs) Regulations, I committed to pursuing further with NHS England ways in which they can clarify the guidelines on the prescribing of liothyronine to CCGs, including looking at whether greater clarity on the criteria for appropriate patient usage is merited.</p><p>The prescribing of Liothyronine (T3) was considered by the Sussex and East Surrey Sustainability and Transformation Partnership (STP) clinical board, which covers Brighton and Sussex University Hospitals, and High Weald, Lewes and Havens CCG, following engagement with primary care clinicians and endocrinologists. Based on the evidence presented, the decision not to routinely prescribe Liothyronine (T3) was supported across the STP region. It was, however, recognised that there would be some exceptions to this and that the use of the individual funding request triage process would be an appropriate mechanism to consider these.</p><p><strong> </strong></p> answering member printed Lord O'Shaughnessy grouped question UIN HL8980 HL8982 HL8983 question first answered 10/07/2018 15:41:18 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

931634

	registered interest
	date	26/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Liothyronine
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of the Brighton and Sussex University Hospitals NHS Trust mistakenly stating that the only option for patients wishing to continue Liothyronine (T3) therapy is through the private sector, contrary to advice issued by NHS England which sets out the circumstances under which Liothyronine (T3) can be prescribed to new patients and continued for existing patients.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL8982
	answer	answer is ministerial correction date of answer 10/07/2018 answer text <p>The national guidelines advise clinical commissioning groups (CCGs) that local decisions should be made regarding arrangements for the on-going prescribing of liothyronine, taking into account the local needs of the population. While CCGs are expected to have regard to national guidance, they are entitled to develop their own local approaches to its implementation. During a debate on 20 June on the Branded Health Service Medicines (Costs) Regulations, I committed to pursuing further with NHS England ways in which they can clarify the guidelines on the prescribing of liothyronine to CCGs, including looking at whether greater clarity on the criteria for appropriate patient usage is merited.</p><p>The prescribing of Liothyronine (T3) was considered by the Sussex and East Surrey Sustainability and Transformation Partnership (STP) clinical board, which covers Brighton and Sussex University Hospitals, and High Weald, Lewes and Havens CCG, following engagement with primary care clinicians and endocrinologists. Based on the evidence presented, the decision not to routinely prescribe Liothyronine (T3) was supported across the STP region. It was, however, recognised that there would be some exceptions to this and that the use of the individual funding request triage process would be an appropriate mechanism to consider these.</p><p><strong> </strong></p> answering member printed Lord O'Shaughnessy grouped question UIN HL8980 HL8981 HL8983 question first answered 10/07/2018 15:41:18 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

931635

	registered interest
	date	26/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Liothyronine
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what action they propose to ensure that NHS bodies withdraw policies of no longer making Liothyronine (T3) available to NHS patients, contrary to advice issued by NHS England which sets out the circumstances under which Liothyronine (T3) can be prescribed to new patients and continued for existing patients.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL8983
	answer	answer is ministerial correction date of answer 10/07/2018 answer text <p>The national guidelines advise clinical commissioning groups (CCGs) that local decisions should be made regarding arrangements for the on-going prescribing of liothyronine, taking into account the local needs of the population. While CCGs are expected to have regard to national guidance, they are entitled to develop their own local approaches to its implementation. During a debate on 20 June on the Branded Health Service Medicines (Costs) Regulations, I committed to pursuing further with NHS England ways in which they can clarify the guidelines on the prescribing of liothyronine to CCGs, including looking at whether greater clarity on the criteria for appropriate patient usage is merited.</p><p>The prescribing of Liothyronine (T3) was considered by the Sussex and East Surrey Sustainability and Transformation Partnership (STP) clinical board, which covers Brighton and Sussex University Hospitals, and High Weald, Lewes and Havens CCG, following engagement with primary care clinicians and endocrinologists. Based on the evidence presented, the decision not to routinely prescribe Liothyronine (T3) was supported across the STP region. It was, however, recognised that there would be some exceptions to this and that the use of the individual funding request triage process would be an appropriate mechanism to consider these.</p><p><strong> </strong></p> answering member printed Lord O'Shaughnessy grouped question UIN HL8980 HL8981 HL8982 question first answered 10/07/2018 15:41:18 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

76553

	registered interest
	date	08/07/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Assistive Technology: Research
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what estimate they have made of the cost of producing internally at the Department of Health the report required under section 22 of the Chronically Sick and Disabled Persons Act 1970 setting out the assistive technology research and development activity under way across the United Kingdom.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL897
	answer	answer is ministerial correction date of answer 17/07/2014 answer text <p>Section 22 of the Chronically Sick and Disabled Persons Act 1970 sets out the following requirement:</p><p> </p><p><em>The Secretary of State shall as respects each year lay before Parliament a report on the progress made during that year in research and development work carried out by or on behalf of any Minister of the Crown in relation to equipment that might increase the range of activities and independence or well-being of disabled persons, and in particular such equipment that might improve the indoor and outdoor mobility of such persons.</em></p><p> </p><p>In recent years the report has been produced by the Foundation for Assistive Technology, and this contract expired in June 2014. The annual cost was £72,268 (figure for final year). The contract was funded by the Department's Policy Research Programme.</p><p> </p><p>The Department has to deliver change in a climate of continuing fiscal challenge and constraint on public spending, and the approach to reporting on assistive technology research and development is aligned with this. The Department does not therefore plan to invite tenders for production of Section 22 reports from 2014-15 and will produce future reports on a smaller scale and of sufficient quality to meet the statutory requirement. This will be done in-house at no additional cost.</p><p> </p><p>As the Government will continue to meet the statutory requirement, no formal consultation on Section 22 has been undertaken or planned.</p><p> </p><p>Reports produced under Section 22, together with other sources of information about Government-funded assistive technology research (including published outputs, project databases, trial registers, websites and other information published by research funders and organisations carrying out research) will continue to make information available that can be used to support the identification of innovation opportunities and the identification and adoption of technology.</p><p> </p> answering member printed Earl Howe grouped question UIN HL898 HL899 HL900 HL901 HL902 HL957 HL958 HL959 question first answered 17/07/2014 11:49:07 answering member 2000 label Biography information for Earl Howe
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

76554

	registered interest
	date	08/07/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Assistive Technology: Research
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what was the planned cost of commissioning the report required under section 22 of the Chronically Sick and Disabled Persons Act 1970 setting out the assistive technology research and development activity under way across the United Kingdom; how that cost compares with their estimate of producing the report internally; and whether the internal report will meet the current standards in term of highlighting technology and outcomes for those with disabilities.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL898
	answer	answer is ministerial correction date of answer 17/07/2014 answer text <p>Section 22 of the Chronically Sick and Disabled Persons Act 1970 sets out the following requirement:</p><p> </p><p><em>The Secretary of State shall as respects each year lay before Parliament a report on the progress made during that year in research and development work carried out by or on behalf of any Minister of the Crown in relation to equipment that might increase the range of activities and independence or well-being of disabled persons, and in particular such equipment that might improve the indoor and outdoor mobility of such persons.</em></p><p> </p><p>In recent years the report has been produced by the Foundation for Assistive Technology, and this contract expired in June 2014. The annual cost was £72,268 (figure for final year). The contract was funded by the Department's Policy Research Programme.</p><p> </p><p>The Department has to deliver change in a climate of continuing fiscal challenge and constraint on public spending, and the approach to reporting on assistive technology research and development is aligned with this. The Department does not therefore plan to invite tenders for production of Section 22 reports from 2014-15 and will produce future reports on a smaller scale and of sufficient quality to meet the statutory requirement. This will be done in-house at no additional cost.</p><p> </p><p>As the Government will continue to meet the statutory requirement, no formal consultation on Section 22 has been undertaken or planned.</p><p> </p><p>Reports produced under Section 22, together with other sources of information about Government-funded assistive technology research (including published outputs, project databases, trial registers, websites and other information published by research funders and organisations carrying out research) will continue to make information available that can be used to support the identification of innovation opportunities and the identification and adoption of technology.</p><p> </p> answering member printed Earl Howe grouped question UIN HL897 HL899 HL900 HL901 HL902 HL957 HL958 HL959 question first answered 17/07/2014 11:49:07 answering member 2000 label Biography information for Earl Howe
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

76555

	registered interest
	date	08/07/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Assistive Technology: Research
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what consultation they have undertaken on the issue of producing internally at the Department of Health the report required under section 22 of the Chronically Sick and Disabled Persons Act 1970 setting out the assistive technology research and development activity under way across the United Kingdom.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL899
	answer	answer is ministerial correction date of answer 17/07/2014 answer text <p>Section 22 of the Chronically Sick and Disabled Persons Act 1970 sets out the following requirement:</p><p> </p><p><em>The Secretary of State shall as respects each year lay before Parliament a report on the progress made during that year in research and development work carried out by or on behalf of any Minister of the Crown in relation to equipment that might increase the range of activities and independence or well-being of disabled persons, and in particular such equipment that might improve the indoor and outdoor mobility of such persons.</em></p><p> </p><p>In recent years the report has been produced by the Foundation for Assistive Technology, and this contract expired in June 2014. The annual cost was £72,268 (figure for final year). The contract was funded by the Department's Policy Research Programme.</p><p> </p><p>The Department has to deliver change in a climate of continuing fiscal challenge and constraint on public spending, and the approach to reporting on assistive technology research and development is aligned with this. The Department does not therefore plan to invite tenders for production of Section 22 reports from 2014-15 and will produce future reports on a smaller scale and of sufficient quality to meet the statutory requirement. This will be done in-house at no additional cost.</p><p> </p><p>As the Government will continue to meet the statutory requirement, no formal consultation on Section 22 has been undertaken or planned.</p><p> </p><p>Reports produced under Section 22, together with other sources of information about Government-funded assistive technology research (including published outputs, project databases, trial registers, websites and other information published by research funders and organisations carrying out research) will continue to make information available that can be used to support the identification of innovation opportunities and the identification and adoption of technology.</p><p> </p> answering member printed Earl Howe grouped question UIN HL897 HL898 HL900 HL901 HL902 HL957 HL958 HL959 question first answered 17/07/2014 11:49:07 answering member 2000 label Biography information for Earl Howe
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

76556

	registered interest
	date	08/07/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Assistive Technology: Research
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of the impact of producing internally at the Department of Health the report required under section 22 of the Chronically Sick and Disabled Persons Act 1970 setting out the assistive technology research and development activity under way across the United Kingdom.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL900
	answer	answer is ministerial correction date of answer 17/07/2014 answer text <p>Section 22 of the Chronically Sick and Disabled Persons Act 1970 sets out the following requirement:</p><p> </p><p><em>The Secretary of State shall as respects each year lay before Parliament a report on the progress made during that year in research and development work carried out by or on behalf of any Minister of the Crown in relation to equipment that might increase the range of activities and independence or well-being of disabled persons, and in particular such equipment that might improve the indoor and outdoor mobility of such persons.</em></p><p> </p><p>In recent years the report has been produced by the Foundation for Assistive Technology, and this contract expired in June 2014. The annual cost was £72,268 (figure for final year). The contract was funded by the Department's Policy Research Programme.</p><p> </p><p>The Department has to deliver change in a climate of continuing fiscal challenge and constraint on public spending, and the approach to reporting on assistive technology research and development is aligned with this. The Department does not therefore plan to invite tenders for production of Section 22 reports from 2014-15 and will produce future reports on a smaller scale and of sufficient quality to meet the statutory requirement. This will be done in-house at no additional cost.</p><p> </p><p>As the Government will continue to meet the statutory requirement, no formal consultation on Section 22 has been undertaken or planned.</p><p> </p><p>Reports produced under Section 22, together with other sources of information about Government-funded assistive technology research (including published outputs, project databases, trial registers, websites and other information published by research funders and organisations carrying out research) will continue to make information available that can be used to support the identification of innovation opportunities and the identification and adoption of technology.</p><p> </p> answering member printed Earl Howe grouped question UIN HL897 HL898 HL899 HL901 HL902 HL957 HL958 HL959 question first answered 17/07/2014 11:49:07 answering member 2000 label Biography information for Earl Howe
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

76557

	registered interest
	date	08/07/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Assistive Technology: Research
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what impact they consider that producing internally at the Department of Health the report required under section 22 of the Chronically Sick and Disabled Persons Act 1970 setting out the assistive technology research and development activity under way across the United Kingdom will have on the identification and adoption of technology that could improve outcomes for people with disabilities and an ageing population.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL901
	answer	answer is ministerial correction date of answer 17/07/2014 answer text <p>Section 22 of the Chronically Sick and Disabled Persons Act 1970 sets out the following requirement:</p><p> </p><p><em>The Secretary of State shall as respects each year lay before Parliament a report on the progress made during that year in research and development work carried out by or on behalf of any Minister of the Crown in relation to equipment that might increase the range of activities and independence or well-being of disabled persons, and in particular such equipment that might improve the indoor and outdoor mobility of such persons.</em></p><p> </p><p>In recent years the report has been produced by the Foundation for Assistive Technology, and this contract expired in June 2014. The annual cost was £72,268 (figure for final year). The contract was funded by the Department's Policy Research Programme.</p><p> </p><p>The Department has to deliver change in a climate of continuing fiscal challenge and constraint on public spending, and the approach to reporting on assistive technology research and development is aligned with this. The Department does not therefore plan to invite tenders for production of Section 22 reports from 2014-15 and will produce future reports on a smaller scale and of sufficient quality to meet the statutory requirement. This will be done in-house at no additional cost.</p><p> </p><p>As the Government will continue to meet the statutory requirement, no formal consultation on Section 22 has been undertaken or planned.</p><p> </p><p>Reports produced under Section 22, together with other sources of information about Government-funded assistive technology research (including published outputs, project databases, trial registers, websites and other information published by research funders and organisations carrying out research) will continue to make information available that can be used to support the identification of innovation opportunities and the identification and adoption of technology.</p><p> </p> answering member printed Earl Howe grouped question UIN HL897 HL898 HL899 HL900 HL902 HL957 HL958 HL959 question first answered 17/07/2014 11:49:08 answering member 2000 label Biography information for Earl Howe
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

76558

	registered interest
	date	08/07/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Assistive Technology: Employment
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of the potential impact on the adoption of technology that would allow people with disabilities to enter the workplace of producing internally at the Department of Health the report required under section 22 of the Chronically Sick and Disabled Persons Act 1970 setting out the assistive technology research and development activity under way across the United Kingdom.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL902
	answer	answer is ministerial correction date of answer 17/07/2014 answer text <p>Section 22 of the Chronically Sick and Disabled Persons Act 1970 sets out the following requirement:</p><p> </p><p><em>The Secretary of State shall as respects each year lay before Parliament a report on the progress made during that year in research and development work carried out by or on behalf of any Minister of the Crown in relation to equipment that might increase the range of activities and independence or well-being of disabled persons, and in particular such equipment that might improve the indoor and outdoor mobility of such persons.</em></p><p> </p><p>In recent years the report has been produced by the Foundation for Assistive Technology, and this contract expired in June 2014. The annual cost was £72,268 (figure for final year). The contract was funded by the Department's Policy Research Programme.</p><p> </p><p>The Department has to deliver change in a climate of continuing fiscal challenge and constraint on public spending, and the approach to reporting on assistive technology research and development is aligned with this. The Department does not therefore plan to invite tenders for production of Section 22 reports from 2014-15 and will produce future reports on a smaller scale and of sufficient quality to meet the statutory requirement. This will be done in-house at no additional cost.</p><p> </p><p>As the Government will continue to meet the statutory requirement, no formal consultation on Section 22 has been undertaken or planned.</p><p> </p><p>Reports produced under Section 22, together with other sources of information about Government-funded assistive technology research (including published outputs, project databases, trial registers, websites and other information published by research funders and organisations carrying out research) will continue to make information available that can be used to support the identification of innovation opportunities and the identification and adoption of technology.</p><p> </p> answering member printed Earl Howe grouped question UIN HL897 HL898 HL899 HL900 HL901 HL957 HL958 HL959 question first answered 17/07/2014 11:49:08 answering member 2000 label Biography information for Earl Howe
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

76615

	registered interest
	date	09/07/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Assistive Technology: Research
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of the impact of producing internally at the Department of Health the report required under section 22 of the Chronically Sick and Disabled Persons Act 1970 on the quality of research into areas of innovative assistive technology and the adoption of such technology; and what measures they intend to take prevent a decrease in both research into and adoption of such technology.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL957
	answer	answer is ministerial correction date of answer 17/07/2014 answer text <p>Section 22 of the Chronically Sick and Disabled Persons Act 1970 sets out the following requirement:</p><p> </p><p><em>The Secretary of State shall as respects each year lay before Parliament a report on the progress made during that year in research and development work carried out by or on behalf of any Minister of the Crown in relation to equipment that might increase the range of activities and independence or well-being of disabled persons, and in particular such equipment that might improve the indoor and outdoor mobility of such persons.</em></p><p> </p><p>In recent years the report has been produced by the Foundation for Assistive Technology, and this contract expired in June 2014. The annual cost was £72,268 (figure for final year). The contract was funded by the Department's Policy Research Programme.</p><p> </p><p>The Department has to deliver change in a climate of continuing fiscal challenge and constraint on public spending, and the approach to reporting on assistive technology research and development is aligned with this. The Department does not therefore plan to invite tenders for production of Section 22 reports from 2014-15 and will produce future reports on a smaller scale and of sufficient quality to meet the statutory requirement. This will be done in-house at no additional cost.</p><p> </p><p>As the Government will continue to meet the statutory requirement, no formal consultation on Section 22 has been undertaken or planned.</p><p> </p><p>Reports produced under Section 22, together with other sources of information about Government-funded assistive technology research (including published outputs, project databases, trial registers, websites and other information published by research funders and organisations carrying out research) will continue to make information available that can be used to support the identification of innovation opportunities and the identification and adoption of technology.</p><p> </p> answering member printed Earl Howe grouped question UIN HL897 HL898 HL899 HL900 HL901 HL902 HL958 HL959 question first answered 17/07/2014 11:49:08 answering member 2000 label Biography information for Earl Howe
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

76616

	registered interest
	date	09/07/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Disability Aids
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what measures they intend to take in order to ensure that the potential internal production of the report required under section 22 of the Chronically Sick and Disabled Persons Act 1970 will not lead to a reduction in the quality of the report.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL958
	answer	answer is ministerial correction date of answer 17/07/2014 answer text <p>Section 22 of the Chronically Sick and Disabled Persons Act 1970 sets out the following requirement:</p><p> </p><p><em>The Secretary of State shall as respects each year lay before Parliament a report on the progress made during that year in research and development work carried out by or on behalf of any Minister of the Crown in relation to equipment that might increase the range of activities and independence or well-being of disabled persons, and in particular such equipment that might improve the indoor and outdoor mobility of such persons.</em></p><p> </p><p>In recent years the report has been produced by the Foundation for Assistive Technology, and this contract expired in June 2014. The annual cost was £72,268 (figure for final year). The contract was funded by the Department's Policy Research Programme.</p><p> </p><p>The Department has to deliver change in a climate of continuing fiscal challenge and constraint on public spending, and the approach to reporting on assistive technology research and development is aligned with this. The Department does not therefore plan to invite tenders for production of Section 22 reports from 2014-15 and will produce future reports on a smaller scale and of sufficient quality to meet the statutory requirement. This will be done in-house at no additional cost.</p><p> </p><p>As the Government will continue to meet the statutory requirement, no formal consultation on Section 22 has been undertaken or planned.</p><p> </p><p>Reports produced under Section 22, together with other sources of information about Government-funded assistive technology research (including published outputs, project databases, trial registers, websites and other information published by research funders and organisations carrying out research) will continue to make information available that can be used to support the identification of innovation opportunities and the identification and adoption of technology.</p><p> </p> answering member printed Earl Howe grouped question UIN HL897 HL898 HL899 HL900 HL901 HL902 HL957 HL959 question first answered 17/07/2014 11:49:08 answering member 2000 label Biography information for Earl Howe
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

76617

	registered interest
	date	09/07/2014
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Disability Aids
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of the impact of the potential internal production of the report required under section 22 of the Chronically Sick and Disabled Persons Act 1970 on the identification of innovation opportunities, particularly for the manufacturing industry and small and medium-sized enterprises.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL959
	answer	answer is ministerial correction date of answer 17/07/2014 answer text <p>Section 22 of the Chronically Sick and Disabled Persons Act 1970 sets out the following requirement:</p><p> </p><p><em>The Secretary of State shall as respects each year lay before Parliament a report on the progress made during that year in research and development work carried out by or on behalf of any Minister of the Crown in relation to equipment that might increase the range of activities and independence or well-being of disabled persons, and in particular such equipment that might improve the indoor and outdoor mobility of such persons.</em></p><p> </p><p>In recent years the report has been produced by the Foundation for Assistive Technology, and this contract expired in June 2014. The annual cost was £72,268 (figure for final year). The contract was funded by the Department's Policy Research Programme.</p><p> </p><p>The Department has to deliver change in a climate of continuing fiscal challenge and constraint on public spending, and the approach to reporting on assistive technology research and development is aligned with this. The Department does not therefore plan to invite tenders for production of Section 22 reports from 2014-15 and will produce future reports on a smaller scale and of sufficient quality to meet the statutory requirement. This will be done in-house at no additional cost.</p><p> </p><p>As the Government will continue to meet the statutory requirement, no formal consultation on Section 22 has been undertaken or planned.</p><p> </p><p>Reports produced under Section 22, together with other sources of information about Government-funded assistive technology research (including published outputs, project databases, trial registers, websites and other information published by research funders and organisations carrying out research) will continue to make information available that can be used to support the identification of innovation opportunities and the identification and adoption of technology.</p><p> </p> answering member printed Earl Howe grouped question UIN HL897 HL898 HL899 HL900 HL901 HL902 HL957 HL958 question first answered 17/07/2014 11:49:08 answering member 2000 label Biography information for Earl Howe
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1649010

	registered interest
	date	29/06/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dental Services: County Durham
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what assessment they have made of the ability of patients in Shildon, Bishop Auckland, and across County Durham to access NHS dental services
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL8921
	answer	answer is ministerial correction date of answer 12/07/2023 answer text <p>The Northeast and North Cumbria Integrated Care Board (ICB) is proactively issuing regular communications updates to patients and local stakeholders regarding the pressures facing National Health Service dentistry locally, whilst seeking to build resilience through local initiatives that seek to improve access to unscheduled urgent dental care for those in greatest clinical need.</p><p>Since taking on NHS Primary Care regulatory dental commissioning responsibility from NHS England on 1 April 2023, the Northeast and North Cumbria ICB have agreed to the establishment of a Local Dental Crisis Task and Finish Group to explore further ways in which the ICB could seek to address NHS dental access and workforce pressures in addition to the</p><p>NHS Long term workforce strategy, and also committed to an independent oral health review of the North East &amp; North Cumbria area with a view to the findings becoming available by October 2023.</p><p>The steps outlined above will help to inform the ICB's future commissioning of NHS dental services. There are no plans to require ICBs to submit proposals on their commissioning of NHS dental services.</p><p>In July 2022, we announced a package of dental system improvements which outlined the steps we are taking to meet oral health need and increase access to dental care across all regions in England. We know more needs to be done and we continue to work with the sector and NHS England to consider further changes which will be announced shortly.</p> answering member printed Lord Markham grouped question UIN HL8922 HL8923 HL8924 question first answered 12/07/2023 12:47:30 answering member 4948 label Biography information for Lord Markham
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1649011

	registered interest
	date	29/06/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dental Services: County Durham
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what steps they plan to take, if any, to increase access to NHS dental services in County Durham.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL8922
	answer	answer is ministerial correction date of answer 12/07/2023 answer text <p>The Northeast and North Cumbria Integrated Care Board (ICB) is proactively issuing regular communications updates to patients and local stakeholders regarding the pressures facing National Health Service dentistry locally, whilst seeking to build resilience through local initiatives that seek to improve access to unscheduled urgent dental care for those in greatest clinical need.</p><p>Since taking on NHS Primary Care regulatory dental commissioning responsibility from NHS England on 1 April 2023, the Northeast and North Cumbria ICB have agreed to the establishment of a Local Dental Crisis Task and Finish Group to explore further ways in which the ICB could seek to address NHS dental access and workforce pressures in addition to the</p><p>NHS Long term workforce strategy, and also committed to an independent oral health review of the North East &amp; North Cumbria area with a view to the findings becoming available by October 2023.</p><p>The steps outlined above will help to inform the ICB's future commissioning of NHS dental services. There are no plans to require ICBs to submit proposals on their commissioning of NHS dental services.</p><p>In July 2022, we announced a package of dental system improvements which outlined the steps we are taking to meet oral health need and increase access to dental care across all regions in England. We know more needs to be done and we continue to work with the sector and NHS England to consider further changes which will be announced shortly.</p> answering member printed Lord Markham grouped question UIN HL8921 HL8923 HL8924 question first answered 12/07/2023 12:47:30 answering member 4948 label Biography information for Lord Markham
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1649012

	registered interest
	date	29/06/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dental Services: North of England
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what assessment they have made of whether the Northeast and North Cumbria Integrated Care Board has undertaken sufficient analysis of the access problems facing NHS dental patients in that area.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL8923
	answer	answer is ministerial correction date of answer 12/07/2023 answer text <p>The Northeast and North Cumbria Integrated Care Board (ICB) is proactively issuing regular communications updates to patients and local stakeholders regarding the pressures facing National Health Service dentistry locally, whilst seeking to build resilience through local initiatives that seek to improve access to unscheduled urgent dental care for those in greatest clinical need.</p><p>Since taking on NHS Primary Care regulatory dental commissioning responsibility from NHS England on 1 April 2023, the Northeast and North Cumbria ICB have agreed to the establishment of a Local Dental Crisis Task and Finish Group to explore further ways in which the ICB could seek to address NHS dental access and workforce pressures in addition to the</p><p>NHS Long term workforce strategy, and also committed to an independent oral health review of the North East &amp; North Cumbria area with a view to the findings becoming available by October 2023.</p><p>The steps outlined above will help to inform the ICB's future commissioning of NHS dental services. There are no plans to require ICBs to submit proposals on their commissioning of NHS dental services.</p><p>In July 2022, we announced a package of dental system improvements which outlined the steps we are taking to meet oral health need and increase access to dental care across all regions in England. We know more needs to be done and we continue to work with the sector and NHS England to consider further changes which will be announced shortly.</p> answering member printed Lord Markham grouped question UIN HL8921 HL8922 HL8924 question first answered 12/07/2023 12:47:30 answering member 4948 label Biography information for Lord Markham
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

1649013

	registered interest
	date	29/06/2023
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Dental Services: North of England
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask His Majesty's Government what plans they have, if any, to require the Northeast and North Cumbria Integrated Care Board to submit proposals to ensure that NHS patients have access to NHS dental services near to where they live.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL8924
	answer	answer is ministerial correction date of answer 12/07/2023 answer text <p>The Northeast and North Cumbria Integrated Care Board (ICB) is proactively issuing regular communications updates to patients and local stakeholders regarding the pressures facing National Health Service dentistry locally, whilst seeking to build resilience through local initiatives that seek to improve access to unscheduled urgent dental care for those in greatest clinical need.</p><p>Since taking on NHS Primary Care regulatory dental commissioning responsibility from NHS England on 1 April 2023, the Northeast and North Cumbria ICB have agreed to the establishment of a Local Dental Crisis Task and Finish Group to explore further ways in which the ICB could seek to address NHS dental access and workforce pressures in addition to the</p><p>NHS Long term workforce strategy, and also committed to an independent oral health review of the North East &amp; North Cumbria area with a view to the findings becoming available by October 2023.</p><p>The steps outlined above will help to inform the ICB's future commissioning of NHS dental services. There are no plans to require ICBs to submit proposals on their commissioning of NHS dental services.</p><p>In July 2022, we announced a package of dental system improvements which outlined the steps we are taking to meet oral health need and increase access to dental care across all regions in England. We know more needs to be done and we continue to work with the sector and NHS England to consider further changes which will be announced shortly.</p> answering member printed Lord Markham grouped question UIN HL8921 HL8922 HL8923 question first answered 12/07/2023 12:47:30 answering member 4948 label Biography information for Lord Markham
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

930914

	registered interest
	date	25/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Drugs: Misuse
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of the extent to which the commissioning guidance for the NHS and local government on how to respond to the needs of people who are addicted to prescription and over the counter medicines, published by Public Health England in June 2013, has been implemented.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL8914
	answer	answer is ministerial correction date of answer 09/07/2018 answer text <p>No assessment has been made of the extent to which the commissioning guidance has been implemented. Responding to the needs of people who are addicted to prescription and over the counter medicines is the responsibility of local authorities and the National Health Service in each area. Local authority and clinical commissioning group commissioners should work together to ensure that there are appropriate services and interventions available to meet the needs of their local populations.</p><p>Public Health England supports local commissioners to better understand and address local need, by publishing guidance and supplying information about people in touch with specialist substance misuse services who are being treated for addiction to medicines.</p><p>People who have developed problems with prescription and over the counter medicines should seek help from their general practitioner (GP) in the first instance. Specialist advice for GPs and support for patients with complex and severe problems is available from substance misuse services in each local authority across the country.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL8915 question first answered 09/07/2018 14:18:52 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

930915

	registered interest
	date	25/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Drugs: Misuse
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government what assessment they have made of the extent to which support is available in every area for people with a dependency on prescription or over the counter medicines as set out in the guidance published by Public Health England in June 2013.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL8915
	answer	answer is ministerial correction date of answer 09/07/2018 answer text <p>No assessment has been made of the extent to which the commissioning guidance has been implemented. Responding to the needs of people who are addicted to prescription and over the counter medicines is the responsibility of local authorities and the National Health Service in each area. Local authority and clinical commissioning group commissioners should work together to ensure that there are appropriate services and interventions available to meet the needs of their local populations.</p><p>Public Health England supports local commissioners to better understand and address local need, by publishing guidance and supplying information about people in touch with specialist substance misuse services who are being treated for addiction to medicines.</p><p>People who have developed problems with prescription and over the counter medicines should seek help from their general practitioner (GP) in the first instance. Specialist advice for GPs and support for patients with complex and severe problems is available from substance misuse services in each local authority across the country.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL8914 question first answered 09/07/2018 14:18:52 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

930912

	registered interest
	date	25/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescription Drugs: Misuse
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government whether they will ensure the timely publication of the agenda, papers and minutes of the Public Health England Expert Group on Prescribed Drug Dependence.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL8912
	answer	answer is ministerial correction date of answer 09/07/2018 answer text <p>Public Health England (PHE) has been commissioned to undertake a public health evidence review of available data and published evidence on the problems associated with dependence, and the short term discontinuation or longer term withdrawal symptoms, associated with prescribed medicines.</p><p> </p><p>PHE is aware of the importance and relevance of the experience of patients in understanding the issues. The review will include a call for papers which specifically identifies published accounts of the patients’ experiences, and this material will be specifically and deliberately focused on in the review. This process is distinct from a public inquiry, which would include individual testimony.</p><p> </p><p>PHE is committed to publishing the agenda, papers and minutes of meetings of the expert reference group and the first set of these documents will be available during July 2018.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL8913 question first answered 09/07/2018 14:17:45 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

930913

	registered interest
	date	25/06/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Prescription Drugs: Misuse
	house id	2
	legislature	25277 pref label House of Lords
	question text	To ask Her Majesty's Government whether the Public Health England Expert Group on Prescribed Drug Dependence will accept as evidence the individual testimonies of patients.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL8913
	answer	answer is ministerial correction date of answer 09/07/2018 answer text <p>Public Health England (PHE) has been commissioned to undertake a public health evidence review of available data and published evidence on the problems associated with dependence, and the short term discontinuation or longer term withdrawal symptoms, associated with prescribed medicines.</p><p> </p><p>PHE is aware of the importance and relevance of the experience of patients in understanding the issues. The review will include a call for papers which specifically identifies published accounts of the patients’ experiences, and this material will be specifically and deliberately focused on in the review. This process is distinct from a public inquiry, which would include individual testimony.</p><p> </p><p>PHE is committed to publishing the agenda, papers and minutes of meetings of the expert reference group and the first set of these documents will be available during July 2018.</p> answering member printed Lord O'Shaughnessy grouped question UIN HL8912 question first answered 09/07/2018 14:17:45 answering member 4545 label Biography information for Lord O'Shaughnessy
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath

752441

	registered interest
	date	17/07/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	house id	2
	legislature	25277 pref label House of Lords
	question text	Her Majesty's Government which organisation is responsible for ensuring that a paediatric audiology service that has not met the standards for Improving Quality in Physiological Services (IQIPS) accreditation addresses the problems found during the accreditation visit.
	tabling member printed	Lord Hunt of Kings Heath
	uin	HL887
	answer	answer is ministerial correction date of answer 20/07/2017 answer text <p>The Improving Quality in Physiological Services (IQIPS) accreditation scheme is run by the United Kingdom Accreditation Service (UKAS). The process of accreditation provides an independent assessment that a service meets the accreditation standards.</p><p> </p><p>It is the responsibility of the service to ensure that they conform to the standard before application to UKAS for accreditation. There is a pre-registration process within the scheme that enables all services to be able to do an effective gap analysis so that they should be at a point of conforming to the standard on making an application to UKAS. If during an assessment mandatory findings are raised which show non-conformity to any part of the standard then the service agrees appropriate improvement actions with the UKAS team to rectify these and prevent re-occurrence.</p><p> </p><p>The UKAS team base their recommendation for accreditation on the findings raised relating to the conformity to the standard, risk and whether the agreed improvement actions are appropriate and can be achieved within a three month close-out period. Therefore any findings raised must be cleared by the organisation if a positive recommendation for accreditation is to be granted.</p><p> </p><p>In <em>Commissioning Services for People with Hearing Loss: A framework for clinical commissioning groups</em>, published in July 2016, NHS England strongly encourages clinical commissioning groups to expect providers to have completed the IQIPS self-assessment tool and applied for accreditation with UKAS, and achieve accreditation within the duration of their contract.</p><p> </p><p>UKAS are supporting the NHS England business objective to increase the use of accreditation, and information about those services which have achieved accreditation is not held by the Department or NHS England, but is publicly available on the UKAS website.</p><p> </p><p>Information on clinical contracts is not held centrally by NHS England.</p> answering member printed Baroness Chisholm of Owlpen grouped question UIN HL889 HL890 HL891 HL979 question first answered 20/07/2017 14:50:43 answering member 4330 label Biography information for Baroness Chisholm of Owlpen
	tabling member	2024 label Biography information for Lord Hunt of Kings Heath